In a medical first, scientists triggered a self-repair mechanism in damaged adult retinas, successfully reversing vision loss .
For decades, science has operated under the assumption that once the adult mammalian retina is damaged, vision loss is permanent.
Unlike fish or birds, which can naturally regenerate eye tissue, humans and other mammals have lacked the biological tools to repair these delicate neural pathways. However, a groundbreaking study by researchers at the Michigan State University College of Veterinary Medicine has shattered this dogma.
Using a single-dose gene therapy in adult dogs suffering from an inherited form of blindness, the team did not just stop the progression of the disease—they witnessed the eye’s physical structure actively rebuilding its own neural connections.
The therapy targets a mutation in the CaBP4 gene, which controls vital calcium signaling between light-sensing cells and the brain. Led by assistant professor Billie Beckwith-Cohen and professor Simon Petersen-Jones, the treatment acted like an editor, supplying corrected genetic blueprints.
Remarkably, the fully developed retinas formed new synaptic connections, thickened, and recovered lost visual function, proving that mature nerve cells retain an unexpected capacity for healing. This discovery opens the door to a new generation of treatments that could one day restore sight to millions of people suffering from complex retinal conditions.
source: Beckwith-Cohen, B., Sun, K., Occelli, L. M., Winkler, P. A., Somma, A. T., Montiani-Ferreira, F., Marinho, L. F. L. P., Schall, P. Z., Parys, M., Yuzbasiyan-Gurkan, V., & Petersen-Jones, S. (2026). Gene therapy induces synaptic ribbon maturation, synaptogenesis and vision recovery in an adult dog model of retinal degeneration. Molecular Therapy Advances.